X

Health Care

Syngene International Ltd Q1FY24; 26% rise in Profits

Syngene (established in 1993) as a Biocon subsidiary is India's first Contract Research Organization (CRO) which expanded later to be…

Novartis India Ltd Q1FY24; 62% fall in Profits

Novartis India Ltd is primarily engaged in the Business of Wholesale of pharmaceuticals and medical goods.It imports various medicines to…

Shalby Ltd Q1FY24; 5% rise in Profits

Shalby Ltd is engaged in healthcare delivery space in India. It operates a chain of multi-specialty hospitals across India. The…

Narayana Hrudayalaya: Play on Affordability?

“Our existing health insurance system operates on a fee-for-service model. It will pay you when you get sick, does nothing…

SastaSundar Ventures – A new player in the e-pharmacy space

“We spent last few years building most efficient Digital Healthcare Platform in terms of Cost, Consumer Experience and Capital. The…

Apollo Hospital: The one stop healthcare service

“At a time when the world is realizing the importance of prevention more than ever before, it is a matter…

Piramal Pharma Q4FY23 Earnings Story

Piramal Pharma Limited (PPL) is part of the Piramal group of companies. The company operates through 3 major segments(1) Contract…

Panacea Biotec Q4FY23 Earnings Story

Panacea Biotec was set up in the year 1984, under the name of Panacea Drugs Private Limited and was publicly…

Natco Pharma Q4FY23 Earnings Story

NATCO Pharma Limited (NATCO) is a vertically integrated, research and development focused pharmaceutical company engaged in developing, manufacturing, and marketing…

Metropolis Healthcare Q4FY23 Earnings Story

Metropolis Healthcare Limited is one of the leading Indian diagnostics companies. The Company owns a chain of diagnostic centres across…

MedPlus Health Services Q4FY23 Earnings

India’s Leading Pharmacy company MedPlus Health Services is the second-largest pharmacy retailer in India in terms of revenue and number…

Krishna Institute of Medical Sciences Q4FY23 Earnings

In terms of the number of patients served and services provided, Krishna Medical Institution Ltd (KIMS), which was founded in…

Apollo Hospitals Enterprise Limited Q4 FY23 Earnings Conference Call Insights

Key highlights from Apollo Hospitals Enterprise Limited (APOLLOHOSP) Q4 FY23 Earnings Concall Management Update: [00:08:21] APOLLOHOSP said it has made…

Venus Remedies Ltd Q4FY23 results out, revenue grows by over 10%

Venus Remedies Ltd is an Indian Pharmaceutical company with a presence in domestic and international markets. It is primarily engaged…

Jubilant Pharmova Q4FY23 Earnings Story

The three business components of Jubilant Pharmova Ltd, which include medicines, contract research and development services, and patented new therapies,…

Apollo Hospitals Enterprise Limited (APOLLOHOSP) Q4 FY23 Earnings Concall Transcript

Apollo Hospitals Enterprise Limited (NSE:APOLLOHOSP) Q4 FY23 Earnings Concall dated May. 31, 2023 Corporate Participants: Mayank Vaswani -- Investor Relations…

Jubilant Pharmova Q4FY23; Reported Losses

Jubilant Pharmova Ltd.’s revenue in Q4FY23 rose 10% to ₹ 1,678 crores. Consolidated Loss After Tax came at ₹ 101…

Hester Biosciences Limited (HESTERBIO) Q4 FY23 Earnings Concall Transcript

Hester Biosciences Limited (NSE:HESTERBIO) Q4 FY23 Earnings Concall dated May. 18, 2023. Corporate Participants: Bimal Lalitsingh Goculdas -- Chief Executive Officer Analysts:…

Hester Biosciences Limited (HESTERBIO) Q4 FY23 Earnings Concall Transcript

Hester Biosciences Limited (NSE:HESTERBIO) Q4 FY23 Earnings Concall dated May. 17, 2023. Corporate Participants: Unidentified Speaker -- Analysts: Nirav Seksaria -- Living Root…

AMI Organics Ltd (AMIORG) Q4 FY23 Earnings Concall Transcript

AMI Organics Ltd (NSE:AMIORG) Q4 FY23 Earnings Concall dated May. 15, 2023. Corporate Participants: Bhavin Shah -- Chief Financial Officer Nareshkumar Ramjibhai…

Dr Lal PathLabs Ltd (LALPATHLAB) Q4 FY23 Earnings Concall Transcript

Dr Lal PathLabs Ltd (NSE:LALPATHLAB) Q4 FY23 Earnings Concall dated May. 11, 2023. Corporate Participants: Hon. Brig. Dr. Arvind Lal -- Executive…